The Digester
general

Blossom Health raises $20 million to deploy AI copilot for psychiatry

New York based Blossom Health raised $20 million to scale an AI 'copilot' for psychiatry that augments clinician decisions and automates clinic workflows, serving hundreds of clinicians and over 10,000 patients across nine states.

Mar 26th 2026 · United States

Insights

  • The company closed $20 million in combined seed and Series A funding led by Headline with participation from Village Global, TA Ventures, Operator Partners, and Correlation Ventures.
  • Blossom positions itself as an AI-native psychiatry platform that augments clinicians and automates back-office tasks.
  • The startup reports hundreds of clinicians using its tools to treat more than 10,000 patients across nine states with in-network coverage and average copays around $22.
  • Its AI agents text patients between visits to monitor symptoms, surface warning signs, and prepare information for clinicians to enable more continuous care and faster access.
  • Founder and CEO John Zhao says clinicians are involved in product development and that features are piloted with over 100 clinicians before wider rollout.
  • Blossom plans to expand beyond nine states, deepen payer relationships, and continue investing in applied AI research and development.

Sources